Back to Search
Start Over
New Rheumatoid Arthritis Findings from Janssen Pharmaceutical Companies Described (Immune Checkpoint Inhibitor Pd-1 Pathway Is Down-regulated In Synovium At Various Stages of Rheumatoid Arthritis Disease Progression)
- Source :
- Immunotherapy Weekly. April 24, 2019, 280
- Publication Year :
- 2019
-
Abstract
- 2019 APR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- New research on Autoimmune Diseases and Conditions - Rheumatoid Arthritis is the subject of a [...]
- Subjects :
- Public Library of Science -- Reports
Development and progression
Reports
Palladium -- Reports
Ipilimumab -- Reports
Arthritis -- Development and progression -- Reports
Medical research -- Reports
Pharmaceutical industry -- Reports
Rheumatoid factor -- Reports
Nivolumab -- Reports
T cells -- Reports
Pembrolizumab -- Reports
Immunotherapy -- Reports
Lymphocytes
Antigens
Antibodies
Editors
Arthralgia
Death
Autoimmune diseases
Genes
Anopheles
Subjects
Details
- Language :
- English
- ISSN :
- 10908625
- Database :
- Gale General OneFile
- Journal :
- Immunotherapy Weekly
- Publication Type :
- News
- Accession number :
- edsgcl.583061163